Protagenic Therapeutics, Inc.
PTIX
$0.49
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.21M | 2.72M | 4.10M | -- | |
| Total Receivables | 41.50K | 44.00K | 98.60K | -- | |
| Inventory | 1.10K | 1.10K | 1.10K | -- | |
| Prepaid Expenses | 43.80K | 90.60K | 135.10K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 2.30M | 2.86M | 4.33M | -- | |
|
|
|||||
| Total Current Assets | 2.30M | 2.86M | 4.33M | -- | |
| Net Property, Plant & Equipment | 38.80K | 51.40K | 64.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 2.09M | 2.09M | 2.09M | -- | |
| Total Assets | 4.43M | 5.00M | 6.49M | -- | |
|
|
|||||
| Total Accounts Payable | 2.03M | 1.64M | 2.08M | -- | |
| Total Accrued Expenses | 252.90K | 408.00K | 505.80K | -- | |
| Short-term Debt | 4.00M | 4.00M | 4.01M | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 544.40K | 3.66M | 3.86M | -- | |
| Total Other Current Liabilities | 544.40K | 3.66M | 3.86M | -- | |
| Total Current Liabilities | 6.82M | 9.70M | 10.46M | -- | |
|
|
|||||
| Total Current Liabilities | 6.82M | 9.70M | 10.46M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | 4.00M | 4.00M | 4.01M | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 6.82M | 9.70M | 10.46M | -- | |
|
|
|||||
| Common Stock & APIC | 6.94M | 6.85M | 6.74M | -- | |
| Retained Earnings | -9.11M | -11.32M | -10.46M | -- | |
| Treasury Stock & Other | -220.00K | -221.20K | -258.20K | -- | |
| Total Common Equity | -2.39M | -4.70M | -3.97M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | -- | |
|
|
|||||
| Total Common Equity | -2.39M | -4.70M | -3.97M | -- | |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -2.39M | -4.70M | -3.97M | -- | |
|
|
|||||